Why Denali Therapeutics Stock Is Soaring Today

Shares of Denali Therapeutics (NASDAQ: DNLI), a biopharmaceutical company focused on neurodegenerative diseases, rose 24% as of 2:36 p.m. EST on Tuesday in response to announcing that its pipeline is progressing.

Here are the key takeaways for investors:

Image source: Getty Images.

Continue reading

Source Fool.com